Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Israel / NCT00031408
Active, not recruiting Observational

Consent for Use of Stored Patient Specimens for Future Testing

NCT00031408 · tracked via the Priya Life Science Israel tracker
Sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Phase
Observational
Started
2002-02-13
Last updated
2025-10-07

Condition(s) studied

HIV Infections

Study summary

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Parent or guardian willing to give informed consent, if applicable * Either currently participating in or have ever participated in an AACTG clinical trial

Trial sites (63)

FacilityCityRegionStatus
Univ of Southern California / LA County USC Med Ctr Los Angeles California
Charles Drew Medical Center Los Angeles California
UCLA CARE Ctr Los Angeles California
Univ of California, San Diego San Diego California
Univ of California San Francisco San Francisco California
San Mateo AIDS Program / Stanford Univ Stanford California
Stanford Univ Med Ctr Stanford California
Willow Clinic / Stanford Univ Stanford California
Harbor General/UCLA Torrance California
Univ of Colorado Health Sciences Ctr Denver Colorado
Georgetown Univ Med Ctr Washington D.C. District of Columbia
Univ of Miami School of Medicine Miami Florida
Emory Univ Atlanta Georgia
Northwestern Univ Med School Chicago Illinois
Rush Presbyterian - Saint Luke's Med Ctr Chicago Illinois
The CORE Ctr Chicago Illinois
Indiana Univ Hosp Indianapolis Indiana
Methodist Hosp of Indiana / Life Care Clinic Indianapolis Indiana
Wishard Hosp Indianapolis Indiana
Department of Internal Medicine, University of Iowa Hospitals & Clinics CRS (1504) Iowa City Iowa
Univ of Maryland, Institute of Human Virology Baltimore Maryland
Johns Hopkins Hosp Baltimore Maryland
Harvard (Massachusetts Gen Hosp) Boston Massachusetts
Boston Med Ctr Boston Massachusetts
Beth Israel Deaconess - West Campus Boston Massachusetts
Brigham and Women's Hosp Boston Massachusetts
Univ of Minnesota Minneapolis Minnesota
Washington Univ / St Louis Connect Care St Louis Missouri
Washington Univ School of Medicine St Louis Missouri
Specialty Care Center CRS 1505 Omaha Nebraska
New Jersey Medical School- Adult CRS (31477) Newark New Jersey
SUNY / Erie County Med Ctr at Buffalo Buffalo New York
Beth Israel Med Ctr New York New York
Cornell Clinical Trials Unit - Chelsea Clinic New York New York
Bellevue Hosp / New York Univ Med Ctr New York New York
Cornell Univ Med Ctr New York New York
The Cornell Clinical Trials Unit New York New York
Mount Sinai Med Ctr New York New York
Columbia Presbyterian Med Ctr New York New York
Community Health Network Inc Rochester New York

+ 23 more sites — see the full list on the official registry below.

Other trials for the same condition

A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy Active, not recruiting
A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT00031408 on ClinicalTrials.gov ↗ ← All trials in Israel